Sotera Health Company (NASDAQ:SHC) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have received a consensus recommendation of “Moderate Buy” from the eleven research firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $21.50.

A number of brokerages have commented on SHC. Barclays upped their price objective on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price target (up from $22.00) on shares of Sotera Health in a research report on Friday, August 7th. Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 29th. Weiss Ratings upgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Finally, JPMorgan Chase & Co. increased their target price on shares of Sotera Health from $16.00 to $18.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th.

Insider Buying and Selling at Sotera Health

In other news, insider Michael P. Rutz sold 150,000 shares of the company’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. This represents a 30.97% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the sale, the chairman directly owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,294,515 shares of company stock valued at $23,999,528 over the last ninety days. Insiders own 15.36% of the company’s stock.

Institutional Investors Weigh In On Sotera Health

A number of large investors have recently bought and sold shares of SHC. BlackRock Inc. acquired a new position in shares of Sotera Health in the 2nd quarter valued at approximately $428,635,000. Sculptor Capital LP acquired a new stake in shares of Sotera Health during the 2nd quarter worth approximately $426,000,000. Vanguard Group Inc. boosted its position in shares of Sotera Health by 16.7% during the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after acquiring an additional 2,756,583 shares in the last quarter. Sachem Head Capital Management LP increased its stake in Sotera Health by 47.2% in the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock valued at $205,418,000 after acquiring an additional 3,735,000 shares during the last quarter. Finally, Janus Henderson Group PLC increased its stake in Sotera Health by 35.3% in the first quarter. Janus Henderson Group PLC now owns 9,162,191 shares of the company’s stock valued at $131,413,000 after acquiring an additional 2,390,132 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Stock Performance

Shares of SHC stock opened at $18.90 on Monday. Sotera Health has a 52 week low of $13.09 and a 52 week high of $19.85. The company has a market capitalization of $5.39 billion, a price-to-earnings ratio of 33.16 and a beta of 1.77. The company has a 50-day simple moving average of $18.35 and a 200 day simple moving average of $16.46. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The firm had revenue of $321.38 million for the quarter, compared to analysts’ expectations of $309.70 million. During the same period in the prior year, the firm earned $0.20 EPS. The business’s revenue was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, sell-side analysts predict that Sotera Health will post 0.86 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.